Recently Updated
- 11/01/2012
- Misoprostol for Treatment of Incomplete Abortion: A Training Guide
- 10/01/2012
- Pre-eclampsia Program Brief
- 09/01/2012
- List of Mifepristone Approvals
- 09/01/2012
- Map of Mifepristone Approvals
- 06/01/2012
- Clinical Studies List
Resources by Last Update
2012
November
Misoprostol for Treatment of Incomplete Abortion: A Training Guide
October
September
List of Mifepristone Approvals
June
Medical Abortion Program Brief
2011
July
June
Misoprostol for Treatment of Postpartum Hemorrhage
2010
November
Postpartum Hemorrhage Program Brief
2009
December
May
Pregnancy Failure and Miscarriage Program Brief
March
Fever after treatment of postpartum hemorrhage
Blood Loss After Vaginal Delivery
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
2008
July
Annotated Bibliography - Misoprostol for Early Abortion
June
Policy and Advocacy Activities Brief
Misoprostol for Incomplete Abortion and Miscarriage
Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage
Combined hormonal contraceptives and venous thromboembolism
Outpatient medical abortion through 70 days
Acceptability of home use of mifepristone for medical abortion
Incomplete abortion in five sub-Saharan African countries
Use of Medicines Changing the Face of Abortion
Misoprostol for the management of postpartum bleeding: A new approach
Misoprostol as first-line treatment for incomplete abortion in Nigeria
Oral misoprostol as first-line care for incomplete abortion in Burkina Faso
Clinic-level introduction of medical abortion in Vietnam
At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion
Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?
First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review
Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam
Misoprostol for postpartum hemorrhage: Moving from evidence to practice
The comparative safety of legal induced abortion and childbirth in the United States
Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia
Treatment approaches for preeclampsia in low-resource settings
Two doses of buccal misoprostol following mifepristone
Misoprostol for the prevention and treatment of postpartum hemorrhage
Misoprostol for Incomplete Abortion in Guatemala
Abortion: What is the problem?
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage
Medical abortion for adolescents
Introduction and provision of medical abortion: A tale of two countries
Exploration of a new procedure for sterilization
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Ultrasound for eligibility assessment for medical abortion
Misoprostol to augment routine active management of the third stage of labor
Misoprostol for PPH prevention in homebirths in Pakistan
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Alternatives to routine ultrasound for eligibility assessment prior to medical abortion
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Self-induction of abortion among women in the United States
Medical abortion: Outcomes in a family medicine setting
Abortion With Self-Administered Misoprostol: A Guide For Women
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
ICMA Third International Conference
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol, Abortion, and the Law
What measured blood loss tells us about postpartum bleeding
High fever following postpartum administration of sublingual misoprostol
Alternatives to Routine Follow-Up for Early Medical Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Home administration of misoprostol for early medical abortion in India
Annotated Bibliography - Mifepristone Medical Abortion
Acceptability and feasibility of medical abortion in Nepal
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Comparison of serum markers for thrombophilia and autoimmune disease
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Non-physician clinicians can safely provide first trimester medical abortion
Increasing women’s choices in medical abortion in Turkey
Sublingual misoprostol for incomplete abortion
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol after mifepristone
Mifepristone medical abortion in Albania
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Abortion and sex determination
Regimens of misoprostol with mifepristone for early medical abortion
Clostridium sordellii infection in medical abortion
Community-based kangaroo mother care to prevent neonatal and infant mortality
Integrating medical abortion into safe abortion services in South Africa
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Two distinct oral routes of misoprostol in mifepristone medical abortion
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Expanding Choice in Abortion Services in Armenia
Abortion in the Middle East and North Africa
STIs/ HIV/ Infectious Disease Program Brief
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Training and Education Activities Brief
Technical Assistance Activities Brief